Those results build on midstage trial data Moderna and Merck released earlier this year, which examined the efficacy of the combination over a shorter period.
from Business News https://ift.tt/diOK83y
Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says
December 14, 2023
0
